Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 8Breast 3Thoracic 2Gastrointestinal 2Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × polyphenon E × Breast × Clear all
NCT01060345 2020-04-09

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

University of Chicago

Phase 2 Terminated
20 enrolled 5 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT00676793 2017-09-21

A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression

Louisiana State University Health Sciences Center Shreveport

Phase 2 Completed
32 enrolled 6 charts
Breast

Breast Neoplasms

NCT00516243 2014-09-12

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡